Molecular Templates, Inc.
Industry
- Pharmaceuticals
- Biotechnology
- Drug Discovery Technologies
- Large Molecule
Other Names/Subsidiaries
- Threshold Pharmaceuticals, Inc.
Latest on Molecular Templates, Inc.
The market for initial public offerings in the US looks like it might be waking up from a month and a half nap with one biopharmaceutical company making it through the IPO window in mid-June and three
ImmunoGen, Inc. and Protagonist Therapeutics, Inc. accomplished in early April what has become increasingly difficult for public biotechnology companies to do when they accessed significant amounts
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MTEM Will Use Platform To Research Canc
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Vertex Partners With Molecul